The observed BACE1 activity in CSF inversely correlating with hippocampal volume supports the hypothesis that elevated BACE1 may induce downstream amyloidogenic effects by triggering stepwise neurodegeneration leading to hippocampal atrophy. The gene discussed is BACE1; the disease is hippocampal atrophy.